EGFR and non-small cell lung carcinoma: Meanwhile, the criteria for synchronous oligometastatic, oligo-residual, and Oligo-PD in patients with EGFR-mutated NSCLC have not been adequately established, and it is necessary to establish globally common criteria to stimulate therapeutic development.